InsidersTradesSigma
Follow the 富士莱 share price and the full insider trade history of the company, a listed equity based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 富士莱 has recorded 3 public disclosures. Market capitalisation: €2.3bn. The latest transaction was reported on 1 June 2026 (Sale). Among the most active insiders: 钱怡. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
富士莱 是一家在XSHE市场上市的医疗保健和制药领域的公司。它专注于药品的开发和分销。